as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. The Lancet, 20 February 2013 (online publication, ahead of print).
[2] Non-Hodgkin lymphoma incidence statistics: In the EU and worldwide. Cancer Research UK. Available at http://www.cancerresearchuk.org/cancer-info/cancerstats/type.... Accessed February 2012
[3] European Age-Standardised rates calculated by the Cancer Research UK Statistical Information Team, 2011, using data from GLOBOCAN 2008 v1.2, IARC, version 1.2 [http://globocan.iarc.fr ]. Available at Non-Hodgkin lymphoma incidence statistics: In the EU and worldwide. Cancer Research UK http://www.cancerresearchuk.org/cancer-info/cancerstats/type.... Accessed February 2012.
CONTACTO: Para obtener más información, póngase en contacto con:Lara Dow Lara.Dow@mundipharma.co.uk, +44(0)7753-579842, Emma-Fleur Hartley,Emma.Hartley@fleishmaneurope.com+44(0)20-7395-7114.
